Factors influencing southern Taiwanese men's acceptance of prostate-specific antigen screening

Lin, Yu-Hua; Li, Hui-Chi; Cheng, Han-Fu; Wu, Youshen; Kao, Chia‐Chan

doi:10.1111/j.1749-771x.2011.01121.x

Cited by 3 publications

(1 citation statement)

References 17 publications

(27 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies have shown that Japanese men were inadequately aware of prostate cancer and of the means available for its early detection, with only 8% of men having heard of PSA testing [24]. Additionally, previous studies have found a low acceptance of PSA testing among Taiwanese men [33] and that 58% of Korean men were not willing to take screenings because of the belief that they were healthy [26].…”

Section: There Is a Gap In Hcp-patient Communicationmentioning

confidence: 99%

Not all prostate cancer is the same – patient perceptions: an Asia‐Pacific region study

Akakura

Bolton

Grillo³

et al. 2020

BJU International

View full text Add to dashboard Cite

Objective To explore the perceptions of patients living with different stages of prostate cancer across the Asia‐Pacific (APAC) region, as while extensive quantitative research has been undertaken into outcomes of treatments for prostate cancer, little in the way of qualitative research has been performed looking at subjective perceptions of patients in regard to their perceived deficits in the treatment of this condition and such research is particularly lacking in reference to the APAC region. Patients and methods Initial 45‐min qualitative research interrogatory interviews were conducted with 12 patients from Australia, China and Japan to identify themes that were significant to patients in the management of prostate cancer. Thereafter, 150 patients with different stages of prostate cancer underwent 30‐min online (Australia) or computer‐assisted/personal interviews categorised on the five key themes identified, in order to more fully clarify the nature of patient perceptions of how their prostate cancer had been treated and the issues they felt could be more fully addressed in order to improve the management of this condition. Results Interviews indicated common challenges and unmet needs among patients, including: (i) patients’ feelings and emotional state change during their disease journey, (ii) patients lack of knowledge about prostate cancer and disease progression prior to diagnosis, (iii) patients felt shared decision‐making was uncommon, (iv) patients have misperceptions about surgery, and (v) patients have unmet needs for greater information and support to manage their condition. Conclusions These patient perceptions of unmet needs in prostate cancer management stand in contrast to patient awareness of other common diseases such as heart failure and diabetes. Such unmet needs vary across disease stages and between different nationalities. Patients with prostate cancer in the APAC region appear to have gaps in knowledge about their disease and wish for greater information, support and public awareness about prostate cancer.

show abstract

Section: There Is a Gap In Hcp-patient Communicationmentioning

confidence: 99%

Not all prostate cancer is the same – patient perceptions: an Asia‐Pacific region study

Akakura

Bolton

Grillo³

et al. 2020

BJU International

View full text Add to dashboard Cite

show abstract

Prostate cancer screening uptake in Kenya: An analysis of the demographic and health survey

Okyere,

Ayebeng,

Owusu

et al. 2023

Journal of Cancer Policy

View full text Add to dashboard Cite

The Impact of Prostate-Specific Antigen Screening on Prostate Cancer Incidence and Mortality in China: 13-Year Prospective Population-Based Cohort Study

Ruan,

Zhang,

Wang

et al. 2024

JMIR Public Health Surveill

View full text Add to dashboard Cite

Background The status of prostate-specific antigen (PSA) screening is unclear in China. Evidence regarding the optimal frequency and interval of serial screening for prostate cancer (PCa) is disputable. Objective This study aimed to depict the status of PSA screening and to explore the optimal screening frequency for PCa in China. Methods A 13-year prospective cohort study was conducted using the Chinese Electronic Health Records Research in Yinzhou study’s data set. A total of 420,941 male participants aged ≥45 years were included between January 2009 and June 2022. Diagnosis of PCa, cancer-specific death, and all-cause death were obtained from the electronic health records and vital statistic system. Hazard ratios (HRs) with 95% CIs were estimated using Cox regression analysis. Results The cumulative rate of ever PSA testing was 17.9% with an average annual percent change (AAPC) of 8.7% (95% CI 3.6%-14.0%) in the past decade in China. People with an older age, a higher BMI, higher waist circumference, tobacco smoking and alcohol drinking behaviors, higher level of physical activity, medication use, and comorbidities were more likely to receive PSA screening, whereas those with a lower education level and a widowed status were less likely to receive the test. People receiving serial screening ≥3 times were at a 67% higher risk of PCa detection (HR 1.67; 95% CI 1.48-1.88) but a 64% lower risk of PCa-specific mortality (HR 0.36; 95% CI 0.18-0.70) and a 28% lower risk of overall mortality (HR 0.72; 95% CI 0.67-0.77). People following a serial screening strategy at least once every 4 years were at a 25% higher risk of PCa detection (HR 1.25; 95% CI 1.13-1.36) but 70% (HR 0.30; 95% CI 0.16-0.57) and 23% (HR 0.77; 95% CI 0.73-0.82) lower risks of PCa-specific and all-cause mortality, respectively. Conclusions This study reveals a low coverage of PSA screening in China and provides the first evidence of its benefits in the general Chinese population. The findings of this study indicate that receiving serial screening at least once every 4 years is beneficial for overall and PCa-specific survival. Further studies based on a nationwide population and with long-term follow-up are warranted to identify the optimal screening interval in China.

show abstract

Factors influencing southern Taiwanese men's acceptance of prostate-specific antigen screening

Cited by 3 publications

References 17 publications

Not all prostate cancer is the same – patient perceptions: an Asia‐Pacific region study

Not all prostate cancer is the same – patient perceptions: an Asia‐Pacific region study

Prostate cancer screening uptake in Kenya: An analysis of the demographic and health survey

The Impact of Prostate-Specific Antigen Screening on Prostate Cancer Incidence and Mortality in China: 13-Year Prospective Population-Based Cohort Study

Contact Info

Product

Resources

About